The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction
Open accessAbstract
Recent studies indicate that inflammasomes serve as intracellular machinery to initiate classical cytokine-mediated inflammatory responses and play a crucial role in the pathogenesis of cardiovascular diseases. However, whether or not the activation of endothelial inflammasomes directly causes cell dysfunction or tissue injury without recruitment of inflammatory cells is unknown. We explored the role of endothelial cell inflammasome activation in mediating tight junction disruption, a hallmark event of endothelial barrier dysfunction leading to endothelial hyperpermeability in diabetes. We used confocal microscopy to study the formation and activation of NOD-like receptor family pyrin domain containing-3 (Nlrp3) inflammasomes and expression of tight junction proteins in coronary arteries of streptozotocin-treated diabetic wild type and Nlrp3 gene-deleted mice. We found that Nlrp3 ablation prevented inflammasome activation and tight junction disassembly in the coronary arterial endothelium of diabetic mice. Similarly, Nlrp3 gene silencing prevented high glucose-induced down-regulation of tight junction proteins in cultured mouse vascular endothelial cells (MVECs). The high glucose-induced tight junction disruption and consequent endothelial permeability were attributed to increased release of the high mobility group box protein-1 (HMGB1), which is dependent on enhanced Nlrp3 inflammasome activity. Mechanistically, reducing reactive oxygen species (ROS) production abolished high glucose-induced inflammasome activation, tight junction disruption, and endothelial hyperpermeability in MVECs. Collectively, the ROS-dependent activation of endothelial Nlrp3 inflammasomes by hyperglycemia may be an important initiating mechanism to cause endothelial dysfunction. These effects could contribute to the early onset of endothelial injury in diabetes.Key message Endothelial tight junction disruption in diabetes requires Nlrp3 inflammasomes. High glucose activates Nlrp3 inflammasome in endothelial cells via ROS production. Activation of endothelial inflammasome by high glucose triggers release of HMGB1. Blockade of Nlrp3/HMGB1 axis inhibits high glucose-induced endothelial permeability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have suggested that ablation of NLRP3 protects endothelial cells from inflammatory damage, leading to attenuation of AS.12, 13”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [13]
In the citing paper
“whereas ablation of NLRP3 protects endothelial cells from inflammatory damage, subsequently attenuating AS.12, 13”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [13]
In the citing paper
“It has also been found that the mtROS‐dependent activation of the endothelial NLRP3 inflammasome by hyperglycemia may be an important initiating mechanism for endothelial dysfunction,13”
From Trimethylamine‐N‐Oxide Induces Vascular Inflammation by Activating the NLRP3 Inflammasome Through the SIRT3‐SOD2‐mtROS Signaling Pathway (2017) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Schroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Activation and regulation of the inflammasomes
Latz, E., Xiao, T. S., & Stutz, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3452 · Cited by 2,884
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
Role of Endothelial Dysfunction in Atherosclerosis
Davignon, J., & Ganz, P. (2004) · Circulation · doi:10.1161/01.cir.0000131515.03336.f8 · Cited by 2,513
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Srinivasan, K. K., Viswanad, B., Asrat, L., Kaul, C. L., & Ramarao, P. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.05.004 · Cited by 1,879
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834
Signaling Mechanisms Regulating Endothelial Permeability
Mehta, D., & Malik, A. B. (2005) · Physiological Reviews · doi:10.1152/physrev.00012.2005 · Cited by 1,754
Cited by
Sorted by citations
Chen, M., Zhu, X., Ran, L., Lang, H., Yi, L., & Mi, M. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006347 · Cited by 600
NLRP3 inflammasome in endothelial dysfunction
Bai, B., Yang, Y., Wang, Q., Li, M., Tian, C., Liu, Y., Aung, L. H. H., Li, P., Yu, T., & Chu, X. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02985-x · Cited by 507
Self-citationZhang, Z., Zhao, L. Q., Zhou, X., Meng, X., & Zhou, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1098725 · Cited by 428
Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction
Boini, K. M., Hussain, T., Li, P.-L., & Koka, S. S. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000484623 · Cited by 302
Self-citationNLRP3 inflammasome pathways in atherosclerosis
Baldrighi, M., Mallat, Z., & Li, X. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.027 · Cited by 204
Self-citationThe role of inflammasomes in vascular cognitive impairment
Poh, L., Sim, W. L., Jo, D., Dinh, Q. N., Drummond, G. R., Sobey, C. G., Chen, C., Lai, M. K. P., Fann, D. Y., & Arumugam, T. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00506-8 · Cited by 167
NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes
Góra, I. M., Ciechanowska, A., & Ładyżyński, P. (2021) · Cells · doi:10.3390/cells10020314 · Cited by 159
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in diabetic retinopathy
Zheng, X., Wan, J., & Tan, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151185 · Cited by 153
Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells
Erdei, J., Tóth, A., Balogh, E., Nyakundi, B. B., Bányai, E., Ryffel, B., Paragh, G., Cordero, M. D., & Jeney, V. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4310816 · Cited by 126
Rovira‐Llopis, S., Apostolova, N., Bañuls, C., Muntané, J., Rocha, M., & Víctor, V. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7313 · Cited by 125
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?
Elrakaybi, A., Laubner, K., Zhou, Q., Hug, M. J., & Seufert, J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101549 · Cited by 118
Inflammation in Metabolic Cardiomyopathy
Wenzl, F. A., Ambrosini, S., Mohammed, S. A., Kraler, S. C., Lüscher, T. F., Costantino, S., & Paneni, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.742178 · Cited by 115
Zhou, X., Wu, Y., Ye, L., Wang, Y., Zhang, K., Wang, L., Huang, Y., Wang, L., Xian, S., Zhang, Y., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.008 · Cited by 110
Self-citationHigh Mobility Group Box 1 Mediates TMAO-Induced Endothelial Dysfunction
Singh, G. B., Zhang, Y., Boini, K. M., & Koka, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143570 · Cited by 103
Self-citationRole of Inflammasomes in Kidney Diseases via Both Canonical and Non-canonical Pathways
Xiang, H., Zhu, F., Xu, Z., & Xiong, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00106 · Cited by 96
Lian, D., Yuan, H., Yin, X.-Z., Wu, Y., He, R., Huang, Y., & Chen, Y. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.10.013 · Cited by 92
Self-citationKnockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells
Song, S., Qiu, D., Luo, F., Wei, J., Wu, M. T., Wu, H., Du, C., Du, Y., Ren, Y., Chen, N., et al. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0069 · Cited by 89
Wang, Y., Wu, J., Wang, J., He, L., Lai, H., Zhang, T., Wang, X., & Li, W. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.01.007 · Cited by 86
Lian, D., Dai, L., Xie, Z., Zhou, X., Liu, X., Zhang, Y., Huang, Y., & Chen, Y. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.10.001 · Cited by 83
Self-citationCheng, J., Liu, Q., Hu, N., Zheng, F., Zhang, X., Ni, Y., & Liu, J. (2019) · Gene · doi:10.1016/j.gene.2019.05.012 · Cited by 79
Nunes, P. R., Viana-Mattioli, S., & Sandrim, V. C. (2021) · Cells · doi:10.3390/cells10112828 · Cited by 77
Zhao, Z., Wang, X., Zhang, R., Ma, B., Niu, S., Di, X., Ni, L., & Liu, C. (2021) · Aging · doi:10.18632/aging.202829 · Cited by 68
Cardiovascular diseases, NLRP3 inflammasome, and western dietary patterns
Pavillard, L. E., Marín‐Aguilar, F., Bullón, P., & Cordero, M. D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.018 · Cited by 67
Zhang, Y., Chen, Y., Zhang, Y., Li, P., & Li, X. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172795 · Cited by 67
Self-citationCellular Stress and General Pathological Processes
Gusev, E. Y., & Zotova, N. V. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319114641 · Cited by 64
Chen, Y., He, X., Yuan, X., Hong, J., Bhat, O. M., Li, G., Li, P., & Guo, J. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2901871 · Cited by 56
Self-citationThom, S. R., Bhopale, V. M., Yu, K., Huang, W., Kane, M. A., & Margolis, D. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.802629 · Cited by 55
Wu, Y., Li, Y., Liao, X., Wang, Z., Li, R., Zou, S., Jiang, T., Zheng, B., Duan, P., & Xiao, J. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21172 · Cited by 55
Nyandwi, J. B., Ko, G. H., Jin, H., Yun, S. P., Park, S. W., & Kim, H. J. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114246 · Cited by 55
Israelov, H., Ravid, O., Atrakchi, D., Rand, D., Goldman, S. E., Bresler, Y., Twitto‐Greenberg, R., Omesi, L., Zaltsman, S. L., Gosselet, F., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01927-w · Cited by 53
Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets
Raman, K. S., & Matsubara, J. A. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1811350 · Cited by 52
Li, X.-X., Ling, S., Hu, M., Ma, Y., Li, Y., & Huang, P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.015 · Cited by 52
Self-citationWu, C., Mao, J., Wang, X., Yang, R., Wang, C., Li, C., & Zhou, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02058-z · Cited by 44
Zuo, R. M., Ye, L.-F., Huang, Y., Song, Z., Wang, L., Zhi, H., Zhang, M., Li, J.-Y., Zhu, L., Xiao, W., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01137-3 · Cited by 46
Self-citationBeltrán-García, J., Osca-Verdegal, R., Pérez‐Cremades, D., Novella, S., Hermenegildo, C., Pallardó, F. V., & García‐Giménez, J. L. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s363693 · Cited by 44
Pyroptosis and Its Regulation in Diabetic Cardiomyopathy
Lu, Y., Lu, Y., Meng, J., & Wang, Z. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.791848 · Cited by 44
The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications
Ding, K., Song, C., Hu, H.-J., Yin, K., Huang, H., & Tang, H. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3790721 · Cited by 43
Jeong, J., Lee, D. H., & Song, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112933 · Cited by 40
The IL-1 family of cytokines. Do they have a role in scleroderma fibrosis?
Artlett, C. M. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.11.012 · Cited by 41
Liu, L., Wang, N., Kalionis, B., Xia, S., & He, Q. (2021) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2021.577763 · Cited by 39
Li, C., Wu, Y., Riehle, A., Orian‐Rousseau, V., Zhang, Y., Gulbins, E., & Grassmé, H. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.6994 · Cited by 39
Self-citationLv, Z.-H., Phuong, T. A., Jin, S., Li, X.-X., & Xu, M. (2017) · Oncotarget · doi:10.18632/oncotarget.20443 · Cited by 37
Self-citationLian, D., Lai, J., Wu, Y., Wang, L., Chen, Y., Zhang, Y., Boini, K. M., Huang, Y., & Chen, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000494656 · Cited by 36
Self-citationShi, C., Yang, H., & Zhang, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00139 · Cited by 36
Zhang, Y., Song, Z., Huang, S., Zhu, L., Liu, T., Shu, H., Wang, L., Huang, Y., & Chen, Y. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma0520-582r · Cited by 34
Self-citationLi, C., Guo, S., Pang, W., & Zhao, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00378 · Cited by 33
The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury
Huang, S., Che, J., Chu, Q., & Zhang, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00140 · Cited by 33
Cheema, A. K., Sarría, L., Bekheit, M., Collado, F., Almenar‐Pérez, E., Martín‐Martínez, E., Alegre, J., Castro‐Marrero, J., FLETCHER, M. A., Klimas, N. G., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15260 · Cited by 31
Ugwoke, C. K., Cvetko, E., & Umek, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020847 · Cited by 38
Expression and Contribution of NLRP3 Inflammasome During the Follicular Development Induced by PMSG
Zhang, Z., Wang, F., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00256 · Cited by 32
Self-citationExosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications
Chen, A., Wang, H., Su, Y., Zhang, C., Qiu, Y., Zhou, Y., Wan, Y., Hu, B., & Li, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.720466 · Cited by 31
Zhang, Y., Zhang, Y.-L., Huang, Q., Huang, C., Jiang, Z., Cai, F., & Shen, J. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s221841 · Cited by 28
Self-citationKinnunen, K., Piippo, N., Loukovaara, S., Hytti, M., Kaarniranta, K., & Kauppinen, A. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0396-4 · Cited by 27
Yuan, X., Bhat, O. M., Lohner, H., Zhang, Y., & Li, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158532 · Cited by 27
Self-citationZhang, C., Abdukerim, M., Abilailieti, M., Tang, L., Ling, Y., & Pan, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.07.017 · Cited by 26
Simvastatin improves lysosome function via enhancing lysosome biogenesis in endothelial cells
Li, X. (2019) · Frontiers in bioscience · doi:10.2741/4807 · Cited by 25
Self-citationAwad, E. M., Ahmed, A. F., El‐Daly, M., Amin, A. H., El‐Tahawy, N. F. G., Wagdy, A., Hollenberg, M. D., & Taye, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113308 · Cited by 26
Yu, W., Jiang, Y., Xu, H., & Zhou, Y. (2023) · Biomedicines · doi:10.3390/biomedicines11020442 · Cited by 26
Recent Advances in Microbiota-Associated Metabolites in Heart Failure
Masenga, S., Povia, J. P., Lwiindi, P., & Kirabo, A. (2023) · Biomedicines · doi:10.3390/biomedicines11082313 · Cited by 28
Soluble uric acid induces inflammation via TLR4/NLRP3 pathway in intestinal epithelial cells.
Ma, C., Yang, X., Lv, Q., Yan, Z., Chen, Z., Xu, D., Liu, X., Yang, W. Q., & Xing, S. (2020) · PubMed Central · doi:10.22038/ijbms.2020.44948.10482 · Cited by 23
Ambroxol for the treatment of fibromyalgia: science or fiction?
Kern, K., & Schwickert, M. (2017) · Journal of Pain Research · doi:10.2147/jpr.s139223 · Cited by 21
Neutrophils Kill Reactive Oxygen Species-Resistant Pseudomonas aeruginosa by Sphingosine
Becker, K. A., Li, X., Seitz, A. P., Steinmann, J., Koch, A., Schuchman, E. H., Kamler, M., Edwards, M. J., Caldwell, C. C., & Gulbins, E. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000482024 · Cited by 19
Self-citationLi, X., Kerindongo, R. P., Preckel, B., Kalina, J.-O., Hollmann, M. W., Zuurbier, C. J., & Weber, N. C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114228 · Cited by 17
Self-citationHe, Y., Chen, X., Wu, M., Hou, X., & Zhou, Z. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1073511 · Cited by 19
Endothelial Dysfunction in Type 2 Diabetes: Targeting Inflammation
Sena, C. M., Carrilho, F., & Seiça, R. M. F. (2018) · InTech eBooks · doi:10.5772/intechopen.76994 · Cited by 21
Yuan, X., Bhat, O. M., Lohner, H., Zhang, Y., & Li, P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00111 · Cited by 17
Self-citationSivasinprasasn, S., Wikan, N., Tocharus, J., Chaichompoo, W., Suksamrarn, A., & Tocharus, C. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109572 · Cited by 17
Guan, Y., Li, X., Umetani, M., Boini, K. M., Li, P., & Zhang, Y. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13146 · Cited by 16
Self-citationThe involvement of autophagy in the maintenance of endothelial homeostasis: The role of mitochondria
Dymkowska, D. (2021) · Mitochondrion · doi:10.1016/j.mito.2020.12.013 · Cited by 15
Li, Y., Shi, D., Zhang, H., Yao, X., Wang, S., Wang, R., & Ren, K. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.669581 · Cited by 16
Role of Trimethylamine N-Oxide in Heart Failure
Jing, L., Zhang, H., Xiang, Q., Hu, H., Zhai, C., Xu, S., & Tian, H. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2507240 · Cited by 16
The effect of A1 adenosine receptor in diabetic megalin loss with caspase-1/IL18 signaling
Tian, D., Shi, X., Zhao, Y., Peng, X., Zou, L., Xu, L., Ma, Y., Wen, Y., Faulhaber‐Walter, R., & Chen, L. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s215531 · Cited by 14
Role of Fluid Milk in Attenuating Postprandial Hyperglycemia and Hypertriglyceridemia
Leary, M. P., & Tanaka, H. (2020) · Nutrients · doi:10.3390/nu12123806 · Cited by 14
Lian, D., Liu, J., Han, R., Jin, J., Zhu, L., Zhang, Y., Huang, Y., Wang, X., Xian, S., & Chen, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16747 · Cited by 13
Self-citationExpression and diagnostic value of lncRNA MALAT1 and NLRP3 in lower limb atherosclerosis in diabetes
Li, J., Wang, C., Shao, C., & Xu, J. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01557-w · Cited by 12
Wang, Y., Moura, A. K., Zuo, R. M., Zhou, W., Wang, Z., Roudbari, K., Hu, J. Z., Li, P., Zhang, Y., & Li, X. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.037460 · Cited by 12
Self-citationShen, J., Zhang, Y., Shen, H., Pan, H., Xu, L., Yuan, L., & Ding, Z. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s186028 · Cited by 10
Self-citationThe Protective Role of Interleukin-37 in Cardiovascular Diseases through Ferroptosis Modulation
Cruz‐Gregorio, A., Amezcua-Guerra, L. M., Fisher-Bautista, B., Romero-Beltrán, A., & Fonseca‐Camarillo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189758 · Cited by 9
Vacca, A., Brosolo, G., Marcante, S., Mora, S. D., Bulfone, L., Porto, A. D., Pagano, C., Catena, C., & Sechi, L. A. (2026) · Nutrients · doi:10.3390/nu18020321 · Cited by 11
Elmileegy, I. M. H., Waly, H. S. A., Alghriany, A. A. I., Khalil, N. S. A., Mahmoud, S. M. M., & Negm, E. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-04250-y · Cited by 9
Zhang, B., Wu, H., Zhang, J., Cong, C., & Zhang, L. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04909-7 · Cited by 9
NLRP3 sparks the Greek fire in the war against lipid‐related diseases
Jiang, S., Xiao, H., Wu, Z. B., Yang, Z. P., Ding, B., Jin, Z., & Yang, Y. (2020) · Obesity Reviews · doi:10.1111/obr.13045 · Cited by 9
Shateri, H., Manafi, B., Tayebinia, H., Karimi, J., & Khodadadi, I. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06208-0 · Cited by 9
Tao, T., Zhu, Y., Shi, Y., Sun, B., Gu, Y. B., & Xu, S. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114047 · Cited by 8
Ali, E., Abdallah, H. I., & El-Sayed, S. (2020) · Journal of Molecular Histology · doi:10.1007/s10735-020-09880-x · Cited by 8
Lian, D., Zhu, L., Yu, Y., Zhang, X., Lin, Y.-K., Liu, J., Han, R., Guo, Y., Cai, D., Xiao, W., et al. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma0821-418r · Cited by 7
Self-citationVitamin C and the management of diabetic foot ulcers: a literature review
Tong, K. P. S., Intine, R. V. A., & Wu, S. (2022) · Journal of Wound Care · doi:10.12968/jowc.2022.31.sup9.s33 · Cited by 7
Li, Y., Ling, P., Li, Y., Wang, Y., Li, G., Qiu, C., Wang, J., & Gong, K. (2024) · PeerJ · doi:10.7717/peerj.16692 · Cited by 6
Chen, Q., Ye, L., Huang, L., You, H., Yu, X., Wang, K., Xiong, S., Liao, W., Wang, X., Li, H., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-94917-y · Cited by 5
Self-citationImpairment of Ceramide-Mediated Endothelial Instant Membrane Resealing During Diabetes Mellitus
Chen, Y., Li, G., Bhat, O. M., Li, X., Zhang, Y., & Li, P. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.910339 · Cited by 5
Self-citationWang, Y., Moura, A. K., Zuo, R. M., Guan, Y., Lee, E. A., Hu, J. Z., Roudbari, K., Wang, Z., Wang, M., Li, P., et al. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00226.2025 · Cited by 5
Self-citationWang, Z., Guo, L., Zhu, C., Li, J., Guo, J., Zhu, X., Li, J., Cui, L., Dong, J., Liu, K., et al. (2024) · Experimental Eye Research · doi:10.1016/j.exer.2024.110096 · Cited by 4
Velatooru, L. R., Arroyave, E., Rippee‐Brooks, M. D., Burch, M., Yang, E., Zhu, B. D., Walker, D. H., Zhang, Y., & Fang, R. (2024) · Infection and Immunity · doi:10.1128/iai.00468-24 · Cited by 3
Self-citationNovel Optical Imaging Probe for the Targeted Visualization of NLRP3 Inflammasomes in Living Retina
Uddin, M. I., Dieckmann, B. W., & Soliman, S. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00999 · Cited by 3
RAGE Axis in the Pathogenesis and Treatment of CNS Neurodegeneration in Long-Term Hyperglycemia
Wasilewska, B., Mazur, U., Kordas, B., Mizia, P., & Juranek, J. K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041881 · Cited by 3
Boff, D., Fagundes, C. T., Russo, R. C., & Amaral, F. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-77658-3_2 · Cited by 2
Wu, Z. M., Chen, S., Dai, Y., Huang, K. Q., Wang, X. Q., Mao, L. S., Yang, C. D., Li, F. F., Li, L. Y., Liu, J. M., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-24-0878 · Cited by 1
Yan, C., Zhou, Y., Wang, H., Fu, J., & Xu, Q. (2025) · PLoS ONE · doi:10.1371/journal.pone.0325620 · Cited by 1
Nugraha, A. P., Yang, K., Pramusita, A., Putranti, N. A. R., Luthfi, M., Ramadhani, N. F., Sitalaksmi, R. M., Situmorang, P. C., Artasasta, M. A., Alhasyimi, A. A., et al. (2025) · Journal of Dental Sciences · doi:10.1016/j.jds.2025.07.003 · Cited by 2
Silva‐Velasco, D. L., dos Passos, R. R., Moraes, R. A., Gonçalves, T. T., Wilczynski, S., Zhang, T., Randar, S., Tobin, J. K., Uline, M. J., Priviero, F. B. M., et al. (2026) · Handbook of experimental pharmacology · doi:10.1007/164_2026_802 · Cited by 1
Metadata
- Authors
- Chen, Y., Wang, L., Pitzer, A. L., Li, X., Li, P.-L., & Zhang, Y.
- Affiliations
- Guangzhou University of Chinese Medicine (CN)
- Virginia Commonwealth University (US)
- University of Houston (US)
- Corresponding author
- Zhang, Yang
- Venue
- Journal of Molecular Medicine
- Published
- 2016-10-25
- Volume
- 94
- Issue
- 12
- Pages
- 1335-1347
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- PMC
- PMC5512566
- OpenAlex
- W2535421876
- Cited by
- 108
- References
- 59
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 9 · 2023: 9 · 2022: 15 · 2021: 12 · 2020: 15 · 2019: 12 · 2018: 11 · 2017: 12 · 2016: 1
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Molecular Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL122937, HL122769, HL057244)
- National Natural Science Foundation of China (81603587)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- NLRP3 inflammasome, endothelial dysfunction, hyperglycemia, diabetes mellitus, tight junction disruption, endothelial hyperpermeability, reactive oxygen species, HMGB1, coronary endothelium, streptozotocin-induced diabetes, vascular endothelial cells, inflammasome activation
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Cell Line, Coronary Vessels, Diabetes Mellitus, Experimental, Endothelium, Vascular, Gene Expression Regulation, Humans, Hyperglycemia, Male, Mice, Inbred C57BL, Oxidation-Reduction, Permeability, Streptozocin, Reactive Oxygen Species, Mice, Knockout, Tight Junctions, HMGB1 Protein, RNA, Small Interfering, Endothelial Cells, Mice, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review